Cros P, Allibert P, Mandrand B, Tiercy J M, Mach B
Nucleic Acid Probes Laboratory, bioMérieux, Lyon, France.
Lancet. 1992 Oct 10;340(8824):870-3. doi: 10.1016/0140-6736(92)93284-t.
Molecular analysis of mutations and polymorphisms that are of medical importance requires both accuracy and simplicity. In organ transplantation there is a need for an HLA typing procedure that combines the remarkable accuracy of oligonucleotide genotyping with the simplicity of conventional serological typing. We describe a simple semiautomated method of HLA class II typing consisting of an oligonucleotide hybridisation assay done on microtitre plates followed by automatic colorimetric reading. Individual HLA-DR generic typing for 30 DR specificities, including subtypes of DR1, DR2, DR13, DR14, and DR52, is done on a single plate. The entire typing assay can be completed in less than 4 hours. The procedure has been validated on more than a thousand haplotypes in prospective DR typing of kidney transplant patients, leukaemic patients, and their potential donors. The simplicity of this assay makes it suitable for routine laboratory use. It can be applied to genetic testing in general, including the testing of patients with multiple mutations.
对具有医学重要性的突变和多态性进行分子分析,既需要准确性,也需要简便性。在器官移植中,需要一种 HLA 分型程序,该程序能将寡核苷酸基因分型的高度准确性与传统血清学分型的简便性结合起来。我们描述了一种简单的 HLA II 类分子半自动分型方法,该方法包括在微量滴定板上进行的寡核苷酸杂交试验,随后进行自动比色读数。在单个平板上可完成针对 30 种 DR 特异性的个体 HLA - DR 通用分型,包括 DR1、DR2、DR13、DR14 和 DR52 的亚型。整个分型试验可在不到 4 小时内完成。该程序已在肾移植患者、白血病患者及其潜在供体的前瞻性 DR 分型中,对一千多个单倍型进行了验证。此试验的简便性使其适用于常规实验室使用。它一般可应用于基因检测,包括对具有多种突变的患者进行检测。